Thermo Fisher updates system to detect Delta and Lambda variants

Thermo Fisher Scientific has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains. First launched in March 2021, the research panel features a customisable menu of verified real-time PCR assays for the identification of SARS-CoV-2 mutations. The panel enables laboratories to track known mutations by selecting from a menu of over 50 assays designed to screen for different variants. The TaqMan SARS-CoV-2 Mutation

Panel is highly scalable, allowing up to hundreds of samples to be run to identify one or multiple mutations so labs can scale their surveillance operations based on testing needs. The TaqMan SARS-CoV-2 Mutation Panel provides results in about an hour and is based on gold standard TaqMan SNP genotyping assay technology, which helps detect and distinguish mutations efficiently. The panel can be used with real-time PCR instruments and technology widely used in labs globally.